Avatrombopag maleate, a novel thrombopoietin receptor agonist, has emerged as a potential therapeutic agent for the management of various myeloid disorders. Its mechanism of action involves boosting platelet https://gregoryfvdf530885.blogdigy.com/unveiling-avatrombopag-maleate-s-promise-in-myeloid-disorders-47965257